BIOVERATIV INC. Capital Expenditures
BIOVERATIV INC. reported Capital Expenditures of $13.10 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2018-02-14
- BIOVERATIV INC. payments to acquire property, plant, and equipment for the quarter ending 2017-12-31 was $1.50M, a 69.39% decline year-over-year.
- BIOVERATIV INC. payments to acquire property, plant, and equipment for the quarter ending 2017-09-30 was $1.00M, a 33.33% decline year-over-year.
- BIOVERATIV INC. payments to acquire property, plant, and equipment for the quarter ending 2017-06-30 was $4.30M, a 207.14% increase year-over-year.
- BIOVERATIV INC. payments to acquire property, plant, and equipment for the quarter ending 2017-03-31 was $6.30M, a 600.00% increase year-over-year.
- BIOVERATIV INC. payments to acquire property, plant, and equipment for fiscal 2017 was $13.10M, a 50.57% increase from fiscal 2016.
- BIOVERATIV INC. payments to acquire property, plant, and equipment for fiscal 2016 was $8.70M, a 17.92% decline from fiscal 2015.
- BIOVERATIV INC. payments to acquire property, plant, and equipment for fiscal 2015 was $10.60M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2017-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $2.50M derived: sum of 2 quarters · filed 2018-02-14 | $6.80M derived: sum of 3 quarters · filed 2018-02-14 | $13.10M 10-K · filed 2018-02-14 |
| 2017-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $5.30M derived: sum of 2 quarters · filed 2017-10-27 | $11.60M 10-Q · filed 2017-10-27 | $16.50M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-06-30 | $4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $10.60M 10-Q · filed 2017-08-03 | $15.50M derived: sum of 3 quarters · filed 2018-02-14 | $17.00M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-03-31 | $6.30M 10-Q · filed 2017-05-12 | $11.20M derived: sum of 2 quarters · filed 2018-02-14 | $12.70M derived: sum of 3 quarters · filed 2018-02-14 | $14.10M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-12-31 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $6.40M derived: sum of 2 quarters · filed 2018-02-14 | $7.80M derived: sum of 3 quarters · filed 2018-02-14 | $8.70M 10-K · filed 2018-02-14 |
| 2016-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $2.90M derived: sum of 2 quarters · filed 2017-10-27 | $3.80M 10-Q · filed 2017-10-27 | |
| 2016-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $2.30M 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $900.00K 10-Q · filed 2017-05-12 | |||
| 2015-12-31 | $10.60M 10-K · filed 2018-02-14 |